Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oryzon Genomics SA (ES:ORY)
BME:ORY
RESEARCH TOOLSreports
Holding ES:ORY?
Track your performance easily
ORY Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€1.55 - €2.39
Previous Close€1.63
Volume58.00
Average Volume (3M)94.46K
Market Cap
€105.04M
Enterprise Value€101.17M
Total Cash (Recent Filing)€21.32M
Total Debt (Recent Filing)€17.44M
Price to Earnings (P/E)―
Beta0.64
Next Earnings
Mar 03, 2025EPS Estimate
-€0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares OutstandingN/A
10 Day Avg. Volume107,720
30 Day Avg. Volume94,458
Standard Deviation0.11
R-Squared0.02
Alpha-0.00397
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)341422.47
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€7.15Price Target Upside330.20% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Oryzon Genomics SA News
PremiumCompany Announcements
Oryzon Genomics Advances Clinical Trials Amid Financial Adjustments
PremiumCompany Announcements
Oryzon Genomics Advances Vafidemstat into Phase III
PremiumCompany Announcements
Oryzon Genomics Announces Bond-to-Share Conversion
PremiumCompany Announcements
Oryzon Genomics Announces Positive BPD Trial Results
PremiumCompany Announcements
Oryzon Genomics Announces Bond-to-Share Conversion
PremiumCompany Announcements
Oryzon Genomics Bonds Converted to SharesOptions Prices
Currently, No data available
---
Ownership Overview
― Insiders
0.04% Mutual Funds
― Other Institutional Investors
99.96% Public Companies and
Individual Investors
ORY FAQ
What was Oryzon Genomics SA’s price range in the past 12 months?
Oryzon Genomics SA lowest stock price was €1.55 and its highest was €2.38 in the past 12 months.
What is Oryzon Genomics SA’s market cap?
Currently, no data Available
When is Oryzon Genomics SA’s upcoming earnings report date?
Oryzon Genomics SA’s upcoming earnings report date is Mar 03, 2025 which is in 109 days.
How were Oryzon Genomics SA’s earnings last quarter?
Oryzon Genomics SA released its earnings results on Oct 24, 2024. The company reported -€0.02 earnings per share for the quarter, missing the consensus estimate of -€0.018 by -€0.002.
Is Oryzon Genomics SA overvalued?
According to Wall Street analysts Oryzon Genomics SA’s price is currently Undervalued.
Does Oryzon Genomics SA pay dividends?
Oryzon Genomics SA does not currently pay dividends.
What is Oryzon Genomics SA’s EPS estimate?
Oryzon Genomics SA’s EPS estimate is -€0.03.
How many shares outstanding does Oryzon Genomics SA have?
Oryzon Genomics SA has 64,664,894 shares outstanding.
What happened to Oryzon Genomics SA’s price movement after its last earnings report?
Oryzon Genomics SA reported an EPS of -€0.02 in its last earnings report, missing expectations of -€0.018. Following the earnings report the stock price went up 0.23%.
Which hedge fund is a major shareholder of Oryzon Genomics SA?
Currently, no hedge funds are holding shares in ES:ORY
---
Oryzon Genomics SA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-15.33%
12-Months-Change
Fundamentals
Return on Equity
-5.05%
Trailing 12-Months
Asset Growth
5.77%
Trailing 12-Months
Company Description
Oryzon Genomics SA
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.
---
ORY Stock 12 Month Forecast
Average Price Target
€7.15
▲(330.20% Upside)
Technical Analysis
Best Analysts Covering ORY
1 Year
1 Year Success Rate
0/3 ratings generated profit
1 Year Average Return
-8.80%
assigned a buy rating last month
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -8.80% per trade.
---